MYCN and neuroblastoma: Risk stratification in NB patients divides cases into low, intermediate, and high-risk groups based on multiple parameters such as histological features, MYCN amplification, DNA ploidy, age, chromosomal alterations (including alterations to 11q), differentiation status, and stage at diagnosis [5,6,7,8,9].